Fibrosis Terminated Phase 2 Trials for CC-90001 (DB18445)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03142191A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary FibrosisTreatment